Clinical Trial to Assess the Safety and Tolerability of the Combination of Low-dose Cytarabine or Azacitidine Plus Venetoclax and Quizartinib in Newly Diagnosed AML Patients Aged Equal or More Than 60 Years Old

Clinical trial NCT04687761 · COMPLETED

Trial details

NCT number: NCT04687761
Sponsor: PETHEMA Foundation
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute De Novo Age More 60yr

Start date: 2020-11-04
Primary completion: 2024-11-30
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.